These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11454170)

  • 1. Pseudopeptides containing the 2-hydrazonoacyl fragment: analogs of the chemotactic agent HCO-Met-Leu-Phe-OMe.
    Torrini I; Nalli M; Paglialunga Paradisi M; Pagani Zecchini G; Lucente G; Spisani S
    J Pept Res; 2001 Jul; 58(1):56-66. PubMed ID: 11454170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs.
    Pagani Zecchini G; Nalli M; Mollica A; Lucente G; Paglialunga Paradisi M; Spisani S
    J Pept Res; 2002 Jun; 59(6):283-91. PubMed ID: 12010519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological activity and conformational studies of geometrically restricted tripeptide analogues of the chemoattractant HCO-Met-Leu-Phe-OMe.
    Boggian M; Vertuani G; Cavicchioni G; Pecoraro R; Scatturin A; Spisani S
    Farmaco; 1997; 52(6-7):439-44. PubMed ID: 9372595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of fMLP pocket dimensions and features using formyltetrapeptides.
    Cavicchioni G; Varani K; Niccoli S; Rizzuti O; Spisani S
    J Pept Res; 1999 Oct; 54(4):336-43. PubMed ID: 10532239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of (Z)-2,3-didehydrophenylalanine and phenylalanine C-terminal residues in determining the chemotactic activity of formylpeptides.
    Torrini I; Zecchini GP; Paradisi MP; Spisani S
    Arch Pharm (Weinheim); 1996 Mar; 329(3):143-8. PubMed ID: 9005813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified chemotactic peptides: synthesis, conformation, and activity of HCO-Thp-Ac6c-Phe-OMe.
    Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Mastropietro G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
    Biopolymers; 1996 Sep; 39(3):327-37. PubMed ID: 8756513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid alpha/beta3-peptides with proteinogenic side chains. Monosubstituted analogues of the chemotactic tripeptide For-Met-Leu-Phe-OMe.
    Giordano C; Lucente G; Mollica A; Nalli M; Pagani Zecchini G; Paglialunga Paradisi M; Gavuzzo E; Mazza F; Spisani S
    J Pept Sci; 2004 Aug; 10(8):510-23. PubMed ID: 15347138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological activity, conformational analysis by NMR and molecular modeling of N-formyl-L-Met-L-Pro-L-Phe-OMe, a proline analogue of the chemotactic peptide N-formyl-L-Met-L-Leu-L-Phe-OH.
    Dugas H; Laroche M; Ptak M; Labbé H
    Int J Pept Protein Res; 1993 Jun; 41(6):595-605. PubMed ID: 8394292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and properties of chemotactic peptide analogs. II. HCO-Met-Leu-Phe-OMe analogs containing cyclic alpha,alpha-disubstituted amino acids as Met and Phe mimicking residues.
    Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Spisani S; Giuliani AL
    Int J Pept Protein Res; 1991 Dec; 38(6):495-504. PubMed ID: 1668096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and activity on human neutrophil functions of fMLF-OMe analogs containing alkyl spacers at the central position.
    Pagani Zecchini G; Morera E; Nalli M; Paglialunga Paradisi M; Lucente G; Spisani S
    Farmaco; 2001 Nov; 56(11):851-8. PubMed ID: 11765037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New fMLF-OMe analogues containing constrained mimics of phenylalanine residue.
    Torrini I; Mastropietro G; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Spisani S
    Arch Pharm (Weinheim); 1998 May; 331(5):170-6. PubMed ID: 9691248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological variation responses in fMLP-OMe analogs, introducing bulky protecting groups on the side-chain of hydrophilic residues at position 2.
    Cavicchioni G; Turchetti M; Spisani S
    J Pept Res; 2002 Oct; 60(4):223-31. PubMed ID: 12366529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biscarbamate analogues of the chemotactic tripeptide fMLF-OMe.
    Zecchini GP; Paradisi MP; Torrini I; Nalli M; Lucente G; Spisani S
    Farmaco; 2000 Apr; 55(4):308-13. PubMed ID: 10966163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of the peptide bond at position 2 in HCO-Met-Leu-Phe-OMe analogues as shown by studies on human neutrophils.
    Cavicchioni G; Breveglieri A; Boggian M; Vertuani G; Reali E; Spisani S
    J Pept Sci; 1996; 2(3):135-40. PubMed ID: 9231322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactive fMLF-OMe analogs containing a N-terminal oximic or formylhydrazonic moiety.
    Torrini I; Paglialunga Paradisi M; Pagani Zecchini G; Lucente G; Mastropietro G; Spisani S
    J Pept Res; 2000 Feb; 55(2):102-9. PubMed ID: 10784026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, conformation, and activity of HCO-Met-delta Z Leu-Phe-OMe, an active analogue of chemotactic N-formyltripeptides.
    Pagani Zecchini G; Paglialunga Paradisi M; Torrini I; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Paci M; Sette M; Di Nola A
    Biopolymers; 1993 Mar; 33(3):437-51. PubMed ID: 8461452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, conformation and biological activity of centrally modified pseudopeptidic analogues of For-Met-Leu-Phe-OMe.
    Giordano C; Lucente G; Masi A; Paglialunga Paradisi M; Sansone A; Spisani S
    Amino Acids; 2007 Sep; 33(3):477-87. PubMed ID: 17021652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity in human neutrophils of di-tripeptides, analogues of the chemotactic fMLP.
    Cavicchioni G; Turchetti M; Spisani S
    Bioorg Med Chem Lett; 2001 Dec; 11(24):3157-9. PubMed ID: 11720864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. fMLP-OMe analogs substituted at the methionine residue: an insight into the receptor properties.
    Cavicchioni G; Monesi LG; Ferretti ME; Fabbri E; Rizzuti O; Spisani S
    Arch Pharm (Weinheim); 1998 Nov; 331(11):368-70. PubMed ID: 9881061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and bioactivity of chemotactic tetrapeptides: fMLF-OMe analogues incorporating spacer aminoacids at the lateral positions.
    Lucente G; Giordano C; Sansone A; Torino D; Spisani S
    Amino Acids; 2009 Jul; 37(2):285-95. PubMed ID: 18636221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.